Lemitias DT 100 Tablet contains Lamotrigine 100mg, an anticonvulsant medication primarily indicated for the treatment of epilepsy and bipolar disorder. Lamotrigine acts by stabilizing neuronal membranes and modulating voltage-sensitive sodium channels, thereby inhibiting the release of excitatory neurotransmitters such as glutamate. This mechanism helps in reducing the frequency and severity of seizures in patients with partial seizures, generalized tonic-clonic seizures, and seizures associated with Lennox-Gastaut syndrome. Additionally, Lamotrigine is effective as a mood stabilizer, preventing the recurrence of depressive episodes in bipolar disorder. Lemitias DT 100 is formulated as a dispersible tablet, allowing for ease of administration and rapid onset of action, which is particularly beneficial for patients with swallowing difficulties. The medication should be initiated at a low dose and titrated gradually to minimize the risk of serious skin reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis. Common adverse effects may include dizziness, headache, blurred vision, and nausea. Lemitias DT 100 should be used under strict medical supervision, with regular monitoring for hypersensitivity reactions and therapeutic response. It is contraindicated in patients with known hypersensitivity to Lamotrigine or any excipients. Caution is advised when co-administered with other antiepileptic drugs due to potential drug interactions.